APA (7th ed.) Citation

I, A., A, G., M, R., A, K., S, B. L., F, T., . . . G, J. (2025). Nanoparticle delivery of AMPK activator 991 prevents its toxicity and improves muscle homeostasis in Duchenne muscular dystrophy. Molecular therapy. Methods & clinical development, 33(3), 101564. https://doi.org/10.1016/j.omtm.2025.101564

Chicago Style (17th ed.) Citation

I, Andreana, et al. "Nanoparticle Delivery of AMPK Activator 991 Prevents Its Toxicity and Improves Muscle Homeostasis in Duchenne Muscular Dystrophy." Molecular Therapy. Methods & Clinical Development 33, no. 3 (2025): 101564. https://doi.org/10.1016/j.omtm.2025.101564.

MLA (9th ed.) Citation

I, Andreana, et al. "Nanoparticle Delivery of AMPK Activator 991 Prevents Its Toxicity and Improves Muscle Homeostasis in Duchenne Muscular Dystrophy." Molecular Therapy. Methods & Clinical Development, vol. 33, no. 3, 2025, p. 101564, https://doi.org/10.1016/j.omtm.2025.101564.